Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

COOPERVISION INC.

US

Last updated September 17, 2026

Information

Country
US
Address
180 THRUWAY PARK DR., W Henrietta, NY, 14586
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
3005724763
DUNS Number
—

Catalogue (111)

Page 3 of 3

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (38)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Aug 22, 2025Z-2606-2025—open, classified

One lot manufactured with an invalid sterilization cycle.

Aug 22, 2025Z-2608-2025—open, classified

One lot manufactured with an invalid sterilization cycle.

Aug 22, 2025Z-2607-2025—open, classified

One lot manufactured with an invalid sterilization cycle.

Jun 16, 2025Z-2166-2025—open, classified

Lens blisters may have an incomplete or leaking seal which may render them unsterile.

Jun 16, 2025Z-2165-2025—open, classified

Lens blisters may have an incomplete or leaking seal which may render them unsterile.

Feb 27, 2025Z-1455-2025—open, classified

a limited number of lots were manufactured with an incorrect cylinder power.

Aug 29, 2024Z-3311-2024—open, classified

Manufactured with a misaligned axis resulting in lenses with the incorrect power, may experience poor visual acuity

Aug 29, 2024Z-3310-2024—open, classified

Manufactured with a misaligned axis resulting in lenses with the incorrect power, may experience poor visual acuity

Feb 14, 2023Z-1282-2023—open, classified

The lenses manufactured in the affected lot were made with a misaligned axis resulting in lenses with the incorrect power.

Jan 26, 2023Z-1197-2023—open, classified

Manufactured with misaligned axis resulting in lenses with the incorrect power, users may experience poor visual acuity

Jan 26, 2023Z-1198-2023—open, classified

Manufactured with misaligned axis resulting in lenses with the incorrect power, users may experience poor visual acuity

Dec 27, 2022Z-1014-2023—open, classified

Lenses may be of the incorrect power. A patient who uses an affected lens may experience poor visual acuity.

May 19, 2021Z-2150-2021—terminated

Misaligned placement of an axis mark can cause the patient to experience blurred vision

May 19, 2021Z-2154-2021—terminated

Misaligned placement of an axis mark can cause the patient to experience blurred vision

May 19, 2021Z-2153-2021—terminated

Misaligned placement of an axis mark can cause the patient to experience blurred vision

May 19, 2021Z-2147-2021—terminated

Misaligned placement of an axis mark can cause the patient to experience blurred vision

May 19, 2021Z-2151-2021—terminated

Misaligned placement of an axis mark can cause the patient to experience blurred vision

May 19, 2021Z-2143-2021—terminated

Misaligned placement of an axis mark can cause the patient to experience blurred vision

May 19, 2021Z-2152-2021—terminated

Misaligned placement of an axis mark can cause the patient to experience blurred vision

May 19, 2021Z-2146-2021—terminated

Misaligned placement of an axis mark can cause the patient to experience blurred vision

May 19, 2021Z-2144-2021—terminated

Misaligned placement of an axis mark can cause the patient to experience blurred vision

May 19, 2021Z-2148-2021—terminated

Misaligned placement of an axis mark can cause the patient to experience blurred vision

May 19, 2021Z-2145-2021—terminated

Misaligned placement of an axis mark can cause the patient to experience blurred vision

May 19, 2021Z-2149-2021—terminated

Misaligned placement of an axis mark can cause the patient to experience blurred vision

Jan 13, 2020Z-1227-2020—terminated

Incorrect power of lenses than the expected

Jan 13, 2020Z-1228-2020—terminated

Incorrect power of lenses than the expected

Feb 21, 2018Z-1515-2018—terminated

The secondary packaging is labeled with an incorrect expiration date.

Feb 21, 2018Z-1516-2018—terminated

The secondary packaging is labeled with an incorrect expiration date.

Feb 21, 2018Z-1517-2018—terminated

The secondary packaging is labeled with an incorrect expiration date.

Feb 21, 2018Z-1518-2018—terminated

The secondary packaging is labeled with an incorrect expiration date.

Sep 1, 2017Z-0691-2018—terminated

The firm identified a labeling error affecting Made-To-Order (MTO) Biofinity XR Toric blister labels. The primary blister reads Biofinity Multifocal Toric in error, and should read Biofinity XR Toric. The outer carton correctly reads Biofinity XR Toric.

Nov 20, 2013Z-0543-2014—terminated

Lots were labeled with incorrect expiration dates on secondary package (carton). The primary package (blister) is marked with the correct expiration date.

Nov 20, 2013Z-0542-2014—terminated

Lots were labeled with incorrect expiration dates on secondary package (carton). The primary package (blister) is marked with the correct expiration date.

Nov 15, 2011Z-0350-2012—terminated

Presence of silicone oil residue on Avaira Sphere Soft Contact Lenses.

Aug 19, 2011Z-0044-2012—terminated

This recall was initiated because of the unintended presence of a residue (silicone oil) on lenses from certain lots of Avaira Toric contact lenses. The company received complaints of temporary hazy or blurry vision and discomfort, most likely caused by transient or reversible swelling of the surface layer of the cornea, which is known as corneal epithelial edema. Corneal epithelial edema results when there is insufficient oxygen to the eye, which may be caused by the presence of residue on the lens. Through laboratory testing and investigation, the company determined the cause of the corneal epithelial edema was a small amount of residue (silicone oil) on the lens.

Aug 28, 2009Z-0125-2010—terminated

Thirty-eight lots of Ocufilcon D 55% 1-Day Toric Contact Lens with a modified packaging solution sold under the brand name ClearSight 1-Day Toric were inadvertently shipped into the US market prior to complete evaluation of the 510(k) by the FDA.

Jul 22, 2003Z-1091-03—terminated

Mislabeled with incorrect sphere power.

Jun 25, 2003Z-0978-03—terminated

The actual sphere power of the lens is lower than the labeled value.

FDA Establishments (1)

Establishments registered with the FDA under this company group, matched by name.

  • CooperVision Limited Eastleigh Hampshire · GB FEI 3002807783